摘要
Abstract
Objective:To investigate the effect of tirofiban on patients with acute ST-segment elevation myocardial infarction(STEMI).Methods:One hundred STEMI patients admitted to Rizhao Heart Hospital from January,2021 to December,2022 were randomly divided into two groups,the control group and the observation group,with 50 cases in each group,receiving percutaneous coronary intervention(PCI)and PCI combined with tirofiban respec-tively.Clinical efficacy of the two groups.Results:The total effective rate,DPV,SPV and CFVR of the observa-tion group were higher than those of the control group,while LVESD and LVEDD were lower,LVEF was higher and the incidence of cardiovascular adverse events was lower than that of the control group,P<0.05).Conclusion:Tirofiban has a significant effect on STEMI interventional therapy,which can promote the improvement of coronary blood flow and cardiac function and reduce the incidence of cardiovascular adverse events.关键词
急性ST段抬高型心肌梗死/介入治疗/替罗非班/经皮冠状动脉介入Key words
Acute ST-segment elevation myocardial infarction/Interventional therapy/Tirofiban/Percutaneous coronary intervention分类
医药卫生
